JAGUAR HEALTH, INC.: 10-Q filed 2015-11-13

Name: JAGUAR HEALTH, INC.: 10-Q filed 2015-11-13
Creator: JAGUAR HEALTH, INC.

What JAGUAR HEALTH, INC. reported in its quarterly report filed 2015-11-13 (fiscal Q3 2015): 28 published measures, 71 facts as tagged in accession 0001104659-15-078779.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-11-13
Fiscal period: fiscal Q3 2015
Accession: 0001104659-15-078779 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All JAGUAR HEALTH, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-09-30	16,641,322	USD
At 2014-12-31	4,506,630	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-09-30	8,275,520	USD
At 2014-12-31	5,436,964	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2015-09-30	8,365,802	USD
At 2014-12-31	-8,235,248	USD
At 2013-12-31	-434,853	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-09-30	10,377,483	USD
At 2014-12-31	845,192	USD
At 2014-09-30	1,665,195	USD
At 2013-12-31	185,367	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-2,960,671	USD	92
2015-01-01 to 2015-09-30	-12,160,729	USD	273
2014-07-01 to 2014-09-30	-2,730,261	USD	92
2014-01-01 to 2014-09-30	-6,640,495	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	23,300	USD	273
2014-01-01 to 2014-09-30	55,149	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-09-30	-21,571,507	USD
At 2014-12-31	-9,410,778	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-09-30	834,387	USD
At 2014-12-31	872,523	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	828,049	USD	273
2014-01-01 to 2014-09-30	105,610	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-2,754,973	USD	92
2015-01-01 to 2015-09-30	-8,602,403	USD	273
2014-07-01 to 2014-09-30	-2,582,041	USD	92
2014-01-01 to 2014-09-30	-6,472,111	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-09-30	11,102,689	USD
At 2014-12-31	3,634,107	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	163,594	USD	92
2015-01-01 to 2015-09-30	3,033,238	USD	273
2014-07-01 to 2014-09-30	148,220	USD	92
2014-01-01 to 2014-09-30	168,384	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-09-30	3,815,866	USD
At 2014-12-31	3,561,964	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-09-30	276,767	USD
At 2014-12-31	698,318	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2015-09-30	8,698	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	2,832,639	USD	92
2015-01-01 to 2015-09-30	8,805,598	USD	273
2014-07-01 to 2014-09-30	2,582,041	USD	92
2014-01-01 to 2014-09-30	6,472,111	USD	273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2015-09-30	256,129	USD
At 2014-12-31	198,029	USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	36,634	USD	92
2015-01-01 to 2015-09-30	87,889	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	1,239,831	USD	92
2015-01-01 to 2015-09-30	4,414,162	USD	273
2014-07-01 to 2014-09-30	1,126,436	USD	92
2014-01-01 to 2014-09-30	3,275,991	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-09-30	2,874,330	shares
At 2014-12-31	2,874,330	shares

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2015-09-30	648,357	USD
At 2014-12-31	1,317,991	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-12,160,729	USD	273
2014-01-01 to 2014-12-31	-8,609,575	USD	365
2014-01-01 to 2014-09-30	-6,640,495	USD	273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-2,960,671	USD	92
2015-01-01 to 2015-09-30	-12,507,103	USD	273
2014-07-01 to 2014-09-30	-2,911,093	USD	92
2014-01-01 to 2014-09-30	-7,106,336	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	1,390,429	USD	92
2015-01-01 to 2015-09-30	3,784,272	USD	273
2014-07-01 to 2014-09-30	1,455,605	USD	92
2014-01-01 to 2014-09-30	3,196,120	USD	273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-42,104	USD	92
2015-01-01 to 2015-09-30	-23,471	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	8,698	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	58,100	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-421,551	USD	273
2014-01-01 to 2014-09-30	617,057	USD	273

Inspect the source

Entity: JAGUAR HEALTH, INC. / CIK 0001585608
Captured: 2026-09-19T11:19:21.338Z
SEC response SHA-256: af3ee699cefd4da13c668b718a731ca589112b762891b8071bb00e127eb329a9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001585608.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))